Akoustis Announces First Tri-Band WiFi CPE Design Win and Filter Orders with Tier-1 OEM
– Second Commercial Design Win for XBAW Filters in Past 30 Days –– Two Bands, Multiple XBAW Filters per WiFi […]
Sound Core Business Growth in q1 2020, GUIDANCE REVISED TO REFLECT PRESENT CONSTRAINTS AND UNCERTAINTIES
Ferrari N.V. (NYSE/MTA: RACE) (“Ferrari” or the “Company”) today announces its consolidated preliminary results mfor the first quarter ended March […]
Akoustis Reports Third Quarter FY20 Results
– Company to Host Investor Update Call Today at 8:00 am ET –Charlotte, N.C., May 04, 2020 (GLOBE NEWSWIRE) —Akoustis […]
Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million
Acquisition of Stemline establishes Menarini’s presence in the U.S. biopharmaceutical oncology market Menarini will support further development of Stemline’s ELZONRIS® and […]
Imara Announces Appointment of Stephen M. Migausky as General Counsel
BOSTON, May 04, 2020 (GLOBE NEWSWIRE) — Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing […]
Akoustis to Participate in the 5th Annual Oppenheimer Emerging Growth Conference on May 12, 2020
Charlotte, N.C., May 04, 2020 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) […]
VBL First-in-class MOSPD2 Antibodies Show Potential for Treatment for CNS Inflammation
TEL AVIV, Israel, May 04, 2020 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq: VBLT) is pleased to announce the publication of […]
Tactile Systems Technology, Inc. Reports First Quarter 2020 Financial Results
MINNEAPOLIS, May 04, 2020 (GLOBE NEWSWIRE) — Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused […]
VBL Therapeutics to Report First Quarter 2020 Financial Results on May 14
TEL AVIV, Israel, May 04, 2020 (GLOBE NEWSWIRE) — VBL Therapeutics (Nasdaq: VBLT), a clinical-stage biotechnology company focused on the […]
AC Immune Reports Q1 2020 Financial Results and Provides Business Update
On track to meet the five clinical milestones expected in 2020 with no modifying guidance as a result of Covid-19Ongoing […]
